Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Analysts think EVGN stock price could increase by 445%

Dec 04, 2024, 12:26 PM
23.03%
What does EVGN do
Evogene develops a computer-biological platform, the Computational Predictive Biology (CPB), to enhance life sciences products using Big Data and AI. Its subsidiaries focus on therapeutics, medical cannabis, ag-biologicals, and more.
4 analysts think EVGN stock price will increase by 445.23%. The current median analyst target is $8.29 compared to a current stock price of $1.52. The lowest analysts target is $5.05 and the highest analyst target is $11.81.
📡️ Health Care
Price Target

More Signals

Feature in Progress
This section is under development. Check back soon for updates!